PRESS RELEASE published on 05/24/2024 at 18:00, 3 months 27 days ago Augros Cosmetic Packaging - Résultats 2023 - Perspectives Augros annonce un chiffre d'affaires de 20,8 M€ en hausse de 2% pour 2023 malgré des résultats financiers mitigés. Perspectives incertaines pour 2024 Chiffre D'affaires Résultats Financiers Perspectives Baisse Augros
BRIEF published on 05/02/2024 at 18:00, 4 months 18 days ago Declaration of AUGROS COSMETIC PACKAGING on its voting rights as of April 2024 Euronext Paris Share Capital Voting Rights Investors AUGROS COSMETIC PACKAGING
BRIEF published on 05/02/2024 at 18:00, 4 months 18 days ago Déclaration de AUGROS COSMETIC PACKAGING sur ses droits de vote à Avril 2024 Euronext Paris Droits De Vote Capital Social Investisseurs AUGROS COSMETIC PACKAGING
PRESS RELEASE published on 05/02/2024 at 17:55, 4 months 18 days ago Déclaration relative aux droits de vote au 30 04 2024 Annonce des informations sur le capital social et les droits de vote d'AUGROS COSMETIC PACKAGING listés sur Euronext Paris, segment de marché Compartiment C Euronext Paris Droits De Vote Capital Social AUGROS COSMETIC PACKAGING Compartiment C
BRIEF published on 04/08/2024 at 17:55, 5 months 12 days ago Déclaration des droits de vote de AUGROS COSMETIC PACKAGING au 31 mars 2024 Marché Financier Euronext Paris Droits De Vote Gouvernance D'Entreprise AUGROS COSMETIC PACKAGING
BRIEF published on 04/08/2024 at 17:55, 5 months 12 days ago Declaration of voting rights of AUGROS COSMETIC PACKAGING as of March 31, 2024 Euronext Paris Voting Rights Corporate Governance Financial Market AUGROS COSMETIC PACKAGING
PRESS RELEASE published on 04/08/2024 at 17:50, 5 months 12 days ago Déclaration relative aux droits de vote au 31 03 2024 Publication du nombre d'actions et de droits de vote d'AUGROS COSMETIC PACKAGING, cotée sur Euronext Paris, segment Compartiment C, code ISIN FR0000061780 Euronext Paris Droits De Vote Capital Social AUGROS COSMETIC PACKAGING Compartiment C
Published on 09/20/2024 at 23:40, 5 hours 45 minutes ago Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Published on 09/20/2024 at 23:30, 5 hours 55 minutes ago Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Published on 09/20/2024 at 23:00, 6 hours 25 minutes ago AI/ML Innovations Inc. Provides Second Status Update
Published on 09/20/2024 at 22:30, 6 hours 55 minutes ago Electric Metals Announces Changes to its Board of Directors
Published on 09/20/2024 at 22:15, 7 hours 10 minutes ago Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Published on 09/20/2024 at 22:58, 6 hours 27 minutes ago Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023
Published on 09/20/2024 at 21:00, 8 hours 25 minutes ago Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Published on 09/20/2024 at 20:14, 9 hours 10 minutes ago EQS-Adhoc: GRAMMER AG sells TMD Group in North America
Published on 09/20/2024 at 19:50, 9 hours 35 minutes ago BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Published on 09/20/2024 at 19:47, 9 hours 38 minutes ago EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma
Published on 09/20/2024 at 17:40, 11 hours 45 minutes ago Availability of the 2024 Half-Year Financial Report
Published on 09/20/2024 at 17:40, 11 hours 45 minutes ago Mise à disposition du Rapport Financier Semestriel 2024